U.S. Patent #9,353,175 has been awarded to Michael Lynes and his collaborators Martine DeVos, Debby Laukens, and Lindsey Devisscherat the University of Gent for the “Use of antagonists targeting metallothionein to treat intestinal inflammation”.

MT2 ribbon diagram